The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreAs Seen in israel21c.org
In the time it takes to read this article, several people in the United States will likely experience a heart attack — according to the CDC, someone in the US suffers from one every 40 seconds.
That morbid statistic highlights the importance of coronary artery disease detection methods, and companies developing them.
One such company is Israeli startup AccuLine (opens in a new tab), which recently secured $4.2 million in seed funding for the development and commercialization of its CORA (Coronary Artery Risk Assessment) system, designed to improve the early detection of coronary artery disease (CAD), a leading cause of heart attacks.
CORA detects two bio-signals in the heart’s electrical activity, providing insights into coronary artery health. The system uses artificial intelligence and machine-learning algorithms to analyze this data, identifying patterns that may indicate CAD.
AccuLine Co-founder and CTO Benny Shani is a Technion alumnus.